NCT05428202View on ClinicalTrials.gov

Phase I Study of GN-037 Cream for Psoriasis

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 28, 2022

Primary Completion Date

April 28, 2022

Study Completion Date

September 30, 2022

Conditions
Psoriasis
Interventions
DRUG

GN037

GN-037 cream containing urea, salicylic acid, retinoic acid and clobetasol 17-propionate and matching placebo

DRUG

Placebo

Placebo cream containing base without active ingredients

Trial Locations (1)

38110

Erciyes University IKUM Center, Kayseri

Sponsors

Collaborators (1)

Monitor CRO
All Listed Sponsors
collaborator

Monitor CRO

INDUSTRY

lead

TC Erciyes University

OTHER

NCT05428202 - Phase I Study of GN-037 Cream for Psoriasis | Biotech Hunter | Biotech Hunter